NEWS

Medlab's Sean Hall: "Time to offer something new" to challenge reliance on opioids

Medlab Clinical Ltd's (ASX:MDC) Sean Hall tells Proactive that the company is building a cannabis-based drug that is the size of a nanoparticle.


Medlab Clinical & QUT Clinical Trial with NRGBiotic for Depression Begins

Medlab Clinical and QUT are conducting a clinical trial to assess NRGBioticTM in the management of depression. The clinical trial follows on from two pilot studies which produced significant results of positive clinical benefits to patients administered magnesium orotate and NRGBioticTM respectively.


Medicinal Cannabis Milestone

Ross Greenwood speaks to Medlab CEO Sean Hall about the first successful shipment of cannabis-based medicine, NanaBis. (NanaBisTM is an investigative new product containing 1:1 ratios of Cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), delivery in a sub micron spray to the oro-buccal membrane.)


NEW PRODUCT

FASTBlend

FastBlend

FASTBlend is a practitioner-only vanilla flavoured, whey protein powder that provides a healthy and convenient way to boost protein intake, along with essential vitamins and minerals.

  • Source of calcium and magnesium, necessary for normal nerve and muscle function, and normal bone structure.
  • B vitamins, support energy usage, and the reduction of tiredness and fatigue.
  • Ideal for patients who require additional protein in their diet, or protein to aid in the recovery from exercise.
More Information
Pharmacy Click And Collect
MEDLAB AT UPCOMING CONFERENCES